This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Porgador, A. Articles by Eisenbach, L. Search for Related Content PubMed PubMed Citation Articles by Porgador, A. Articles by Eisenbach, L.

Interleukin 6 Gene Transfection into Lewis Lung Carcinoma Tumor Cells Suppresses the Malignant Phenotype and Confers Immunotherapeutic Competence against Parental Metastatic Cells¹

Departments of Cell Biology [A. P., E. T., A. K., E. V., M. F., L. E.] and Molecular Genetics and Virology [M. R.], Weizmann Institute of Science, Rehovot, 76100, Israel

To investigate the influence of interleukin 6 (IL-6) production on malignancy of tumor cells we transfected cells of the high-metastatic, low-immunogenic D122 clone of the Lewis lung carcinoma with a mammalian expression vector containing the human IL-6 complementary DNA. In vitro, IL-6 positive transfectants showed growth inhibition that was directly correlated with the levels of IL-6 production. The in vitro growth arrest did not seem to be a function of an autocrine system mediated via the secreted human IL-6 acting on the tumor cell surface receptors since neutralizing antibodies to human IL-6 did not prevent the growth inhibition. Neither did exogenous human recombinant IL-6 affect the growth of D122 cells. In vivo, IL-6 positive transfectants showed reduction of tumorigenicity and significant suppression of metastatic competence in syngeneic, immunocompetent mice. In mature T-cell deficient nude mice, the IL-6 transfectants showed some arrest of local growth but no suppression of lung metastasis. It seems therefore that the reduction of metastatic competence of IL-6 transfectants is primarily a function of stimulation by the transfectants of host T-cell immune responses. Immunization with inactivated high-positive IL-6 transfectants induced high levels of anti-tumor cytotoxic T-lymphocytes and protected mice against metastatic growth of a subsequent graft of parental tumor cells. Moreover, reduction of metastatic growth of parental highly metastatic D122 cells was also achieved when immunization of mice was begun after establishment of the primary parental tumors. Thus, inactivated IL-6 transfectants were effective when used as a cellular vaccine for experimental immunotherapy of metastasis.

¹ This work was supported by the Mildred Scheel Foundation, Bonn, Germany, by the US-Israel Binational Foundation, by the Regina Levi Foundation, and by a grant from the National Cancer Institute (CA 28139).

² To whom requests for reprints should be addressed

Received 1/21/92. Accepted 4/24/92.

This article has been cited by other articles:

				E. Voronov, D. S. Shouval, Y. Krelin, E. Cagnano, D. Benharroch, Y. Iwakura, C. A. Dinarello, and R. N. Apte IL-1 is required for tumor invasiveness and angiogenesis PNAS, March 4, 2003; 100(5): 2645 - 2650. [Abstract] [Full Text] [PDF]

				F. Benchetrit, A. Ciree, V. Vives, G. Warnier, A. Gey, C. Sautes-Fridman, F. Fossiez, N. Haicheur, W. H. Fridman, and E. Tartour Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism Blood, March 15, 2002; 99(6): 2114 - 2121. [Abstract] [Full Text] [PDF]

				M. R. Graf, R. M. Prins, and R. E. Merchant IL-6 Secretion by a Rat T9 Glioma Clone Induces a Neutrophil-Dependent Antitumor Response with Resultant Cellular, Antiglioma Immunity J. Immunol., January 1, 2001; 166(1): 121 - 129. [Abstract] [Full Text] [PDF]

				S. A. Ali, C. S. McLean, M. E. G. Boursnell, G. Martin, C. L. Holmes, S. Reeder, C. Entwisle, D. M. Blakeley, J. G. Shields, S. Todryk, et al. Preclinical Evaluation of "Whole" Cell Vaccines for Prophylaxis and Therapy Using a Disabled Infectious Single Cycle-Herpes Simplex Virus Vector to Transduce Cytokine Genes Cancer Res., March 1, 2000; 60(6): 1663 - 1670. [Abstract] [Full Text]

				E. S. Lambright, D. J. Caparrelli, A. E. Abbas, T. Toyoizumi, G. Coukos, K. L. Molnar-Kimber, and L. R. Kaiser Oncolytic therapy using a mutant type-1 herpes simplex virus and the role of the immune system Ann. Thorac. Surg., November 1, 1999; 68(5): 1756 - 1760. [Abstract] [Full Text] [PDF]

				R. Zhang, F. H. Straus, and L. J. DeGroot Effective Genetic Therapy of Established Medullary Thyroid Carcinomas with Murine Interleukin-2: Dissemination and Cytotoxicity Studies in a Rat Tumor Model Endocrinology, May 1, 1999; 140(5): 2152 - 2158. [Abstract] [Full Text]

				H. Tanaka, H. Yoshizawa, Y. Yamaguchi, K. Ito, H. Kagamu, E. Suzuki, F. Gejyo, H. Hamada, and M. Arakawa Successful Adoptive Immunotherapy of Murine Poorly Immunogenic Tumor with Specific Effector Cells Generated from Gene-Modified Tumor-Primed Lymph Node Cells J. Immunol., March 15, 1999; 162(6): 3574 - 3582. [Abstract] [Full Text] [PDF]

				T. F. Greten and E. M. Jaffee Cancer Vaccines J. Clin. Oncol., March 1, 1999; 17(3): 1047 - 1047. [Abstract] [Full Text] [PDF]

				E. Voronov, Y. Weinstein, D. Benharroch, E. Cagnano, R. Ofir, M. Dobkin, R. M. White, M. Zoller, V. Barak, S. Segal, et al. Antitumor and Immunotherapeutic Effects of Activated Invasive T Lymphoma Cells That Display Short-Term Interleukin 1{{alpha}} Expression Cancer Res., March 1, 1999; 59(5): 1029 - 1035. [Abstract] [Full Text] [PDF]

				M. Bihl, M. Tamm, M. Nauck, H. Wieland, A. P. Perruchoud, and M. Roth Proliferation of Human Non-Small-Cell Lung Cancer Cell Lines: Role of Interleukin-6 Am. J. Respir. Cell Mol. Biol., October 1, 1998; 19(4): 606 - 612. [Abstract] [Full Text]

				J. Sancéau, T. Kaisho, T. Hirano, and J. Wietzerbin Triggering of the Human Interleukin-6 Gene by Interferon-[IMAGE] and Tumor Necrosis Factor-alpha in Monocytic Cells Involves Cooperation between Interferon Regulatory Factor-1, NFkappaB, and Sp1 Transcription Factors J. Biol. Chem., November 17, 1995; 270(46): 27920 - 27931. [Abstract] [Full Text] [PDF]

				T. Kundig, M. Bachmann, C DiPaolo, J. Simard, M Battegay, H Lother, A Gessner, K Kuhlcke, P. Ohashi, H Hengartner, et al. Fibroblasts as efficient antigen-presenting cells in lymphoid organs Science, June 2, 1995; 268(5215): 1343 - 1347. [Abstract] [PDF]